Show menu

News

image
SEQENS announces the appointement of a new CEO
France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued
Read more
image
Focus on : Precious transition metal catalysts replacement
Read more
image
Ergonomics at the workstation
Read more
image
Meeting with Pirjo LUOMA-TOKOI for the International Day of Women and Girls in Science
Read more
image
Meeting with Juliette Martin for the International Women’s Day
Read more
image
Remote audits: an interesting alternative to maintain the quality link with customers and suppliers
Read more
image
Biocatalyst for Sucrose conversion into Fructo-Oligosaccharides
Read more
image
Deviation management at SEQENS
Read more
image
Safety – The genesis: from laboratory to factory
Read more
image
Safety is at the heart of our activities
Read more
image
Decarbonization: SEQENS becomes a reference for the industry
Read more
image
Developing and producing critical molecules in France
Read more
image
A new 45,000 tons ISOPROPANOL production facility
Read more
1 4 5 6 7